Molecular Biology

Date: January 6, 1992, pp.16 H.-M. Jantzen, A. Admon, S.P. Bell, R. Tjian, "Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins," Nature, 344:830-36, 1990. (MOLECULAR BIOLOGY) H.-Michael Jantzen (Howard Hughes Medical Institute, University of California, Berkeley): "During the past few years there has been tremendous progress in the identification of transcription factors that bind to specific promoter sequences of eukaryotic genes. However, little is

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share


Date: January 6, 1992, pp.16

H.-M. Jantzen, A. Admon, S.P. Bell, R. Tjian, "Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins," Nature, 344:830-36, 1990. (MOLECULAR BIOLOGY)

H.-Michael Jantzen (Howard Hughes Medical Institute, University of California, Berkeley): "During the past few years there has been tremendous progress in the identification of transcription factors that bind to specific promoter sequences of eukaryotic genes. However, little is known about the molecular mechanisms by which these proteins operate to regulate transcription initiation.

"We have isolated a gene encoding the human transcription factor hUBF [human upstream binding factor], which interacts with the essential factor SL1 to activate transcription of ribosomal RNA by RNA polymerase I in the nucleolus. hUBF is the first of a growing number of transcription factors that has a DNA-binding domain homologous to the chromosomal proteins HMG [high mobility group] 1 and 2, thus defining a new ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies